secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2024-02-23T23:59:59+00:00
Accession:  0001104659-24-027049
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio engages Withum as new auditor; discloses material weakness in internal controls
--------------------------------------------------------------------------------

- Engaged WithumSmith+Brown as independent auditor for FY 2023, replacing Marcum LLP.
- Marcum's report on Dec 31, 2022 financials contained no adverse opinion or qualification.
- Management identified a material weakness related to accounting for complex financial instruments and IPO proceeds.
- No disagreements with Marcum on accounting principles or audit scope during the period.
- Marcum provided a letter agreeing with the disclosures, filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465924027049/0001104659-24-027049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465924027049/tm242343d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-027049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer